Axogen, Inc. (LON:0HKD)
London · Delayed Price · Currency is GBP · Price in USD 30.01
+0.08 (0.26%)
At close: Dec 12, 2025
Axogen Market Cap
Axogen has a market cap or net worth of 1.05 billion as of December 12, 2025. Its market cap has increased by 122.36% in one year.
Market Cap
1.05B
Enterprise Value
1.07B
Revenue
159.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.01
Market Cap Chart
Since October 3, 2011, Axogen's market cap has increased from 7.54M to 1.05B, an increase of 13,810.71%. That is a compound annual growth rate of 41.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 1.03B | 77.88% |
| Dec 31, 2024 | 579.31M | 151.00% |
| Dec 29, 2023 | 230.80M | -34.10% |
| Dec 30, 2022 | 350.26M | 21.78% |
| Dec 31, 2021 | 287.61M | -45.33% |
| Dec 31, 2020 | 526.08M | -1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.41B |
| Haleon | 31.72B |
| Smith & Nephew | 10.61B |
| Convatec Group | 4.39B |
| Hikma Pharmaceuticals | 3.39B |
| HUTCHMED (China) | 1.77B |
| Genus | 1.73B |